Unconfigured Ad
Collapse
Sequencing by Oligo Ligation/Detection (Life Technologies)
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-11-2007, 11:23 PM
|
63 responses
233,882 views
0 reactions
|
Last Post
|
||
|
Started by exprofiler, 09-22-2008, 08:10 AM
|
36 responses
56,611 views
0 reactions
|
Last Post
by ringo1230
10-30-2012, 11:04 PM
|
||
|
Started by john1923, 04-11-2011, 06:22 AM
|
2 responses
2,429 views
0 reactions
|
Last Post
by john1923
04-12-2011, 02:47 AM
|
||
|
Started by Dan_cham, 04-11-2011, 08:07 AM
|
1 response
2,142 views
0 reactions
|
Last Post
by colindaven
04-11-2011, 11:18 PM
|
||
|
Started by pmiguel, 03-03-2011, 01:11 PM
|
20 responses
4,724 views
0 reactions
|
Last Post
by DNADEB
04-08-2011, 11:40 AM
|
||
|
Started by pmiguel, 04-06-2011, 05:00 AM
|
0 responses
2,526 views
0 reactions
|
Last Post
by pmiguel
04-06-2011, 05:00 AM
|
||
|
Started by Mr Mutundes, 04-05-2011, 03:03 PM
|
0 responses
1,350 views
0 reactions
|
Last Post
by Mr Mutundes
04-05-2011, 03:03 PM
|
||
|
Started by scheidp, 04-02-2011, 06:19 PM
|
1 response
1,398 views
0 reactions
|
Last Post
by SeqAA
04-03-2011, 07:40 PM
|
||
|
Started by tdm, 03-30-2011, 10:37 AM
|
10 responses
4,661 views
0 reactions
|
Last Post
by pmiguel
03-31-2011, 08:48 AM
|
||
|
Started by glocke, 03-17-2011, 07:12 AM
|
13 responses
4,170 views
0 reactions
|
Last Post
by sinaian
03-28-2011, 07:00 PM
|
||
|
Started by ryuky, 03-21-2011, 03:40 AM
|
1 response
2,425 views
0 reactions
|
Last Post
by schmima
03-23-2011, 12:45 AM
|
||
|
Started by chenwb, 03-18-2011, 04:37 AM
|
1 response
2,324 views
0 reactions
|
Last Post
by SeqAA
03-18-2011, 07:58 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 10:35 AM
|
0 responses
3 views
0 reactions
|
Last Post
by SEQadmin2
Today, 10:35 AM
|
||
|
Started by SEQadmin2, 08-06-2026, 07:41 AM
|
0 responses
23 views
0 reactions
|
Last Post
by SEQadmin2
08-06-2026, 07:41 AM
|
||
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
40 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|